Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 6
2006 8
2007 8
2008 1
2009 13
2010 7
2011 11
2012 5
2013 6
2014 8
2015 10
2016 13
2017 20
2018 25
2019 22
2020 18
2021 17
2022 7
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study.
Ladouceur A, Barnetche T, Mouterde G, Tison A, Bitoun S, Prey S, Dutriaux C, Gerard E, Pham-Ledard A, Beylot-Barry M, Zysman M, Veillon R, Domblides C, Daste A, Gross-Goupil M, Sionneau B, Lefort F, Larroquette M, Richez C, Truchetet ME, Schaeverbeke T, Kostine M. Ladouceur A, et al. Among authors: schaeverbeke t. RMD Open. 2023 Nov 29;9(4):e003795. doi: 10.1136/rmdopen-2023-003795. RMD Open. 2023. PMID: 38030233 Free PMC article.
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.
Kedra J, Dieudé P, Giboin C, Marotte H, Salliot C, Schaeverbeke T, Perdriger A, Soubrier M, Morel J, Constantin A, Dernis E, Royant V, Salmon JH, Pham T, Gottenberg JE, Pertuiset E, Dougados M, Devauchelle-Pensec V, Gaudin P, Cormier G, Goupille P, Mariette X, Berenbaum F, Alcaix D, Rouidi SA, Berthelot JM, Monnier A, Piroth C, Lioté F, Goëb V, Gaujoux-Viala C, Chary-Valckenaere I, Hajage D, Tubach F, Fautrel B; CRI‐IMIDIATE clinical research network. Kedra J, et al. Among authors: schaeverbeke t. Arthritis Rheumatol. 2024 Apr;76(4):541-552. doi: 10.1002/art.42752. Epub 2024 Jan 25. Arthritis Rheumatol. 2024. PMID: 37942714 Clinical Trial.
Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry.
Nguyen Y, Mariette X, Gottenberg JE, Iudici M, Morel J, Vittecoq O, Constantin A, Flipo RM, Schaeverbeke T, Sibilia J, Ravaud P, Porcher R, Seror R. Nguyen Y, et al. Among authors: schaeverbeke t. Rheumatology (Oxford). 2023 Sep 19:kead495. doi: 10.1093/rheumatology/kead495. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37725356
Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry.
Faganello D, Bertrand A, Meunier P, Avouac J, Toussirot E, Coury F, Seror R, Le Mélédo G, Germain V, Dellal A, Shima D, Hulin C, Prati C, Schaeverbeke T, Richez C, Truchetet ME, Kostine M. Faganello D, et al. Among authors: schaeverbeke t. Rheumatology (Oxford). 2024 Mar 1;63(3):787-790. doi: 10.1093/rheumatology/kead187. Rheumatology (Oxford). 2024. PMID: 37540112
Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization.
Enaud R, Lussac-Sorton F, Charpentier E, Velo-Suárez L, Guiraud J, Bui S, Fayon M, Schaeverbeke T, Nikolski M; LumIvaBiota Study Group; Burgel PR, Héry-Arnaud G, Delhaes L. Enaud R, et al. Among authors: schaeverbeke t. Microbiol Spectr. 2023 Mar 27;11(2):e0225122. doi: 10.1128/spectrum.02251-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36971560 Free PMC article.
FRENCH-ARRIVE: a serious, evidence-free, and false accusation of unethical research.
Sentilhes L, Allart JB, Berveiller P, Bibes A, Schaeverbeke T; FRENCH-ARRIVE Study Group and the Groupe de Recherche en Obstétrique et Gynécologie. Sentilhes L, et al. Among authors: schaeverbeke t. Lancet. 2023 Mar 11;401(10379):819-820. doi: 10.1016/S0140-6736(23)00133-2. Lancet. 2023. PMID: 36906343 No abstract available.
Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study.
Lopez L, Barnetche T, Galli G, Seneschal J, Blanchard E, Shipley E, Pellegrin JL, Lazaro E, Constans J, Duffau P, Schaeverbeke T, Richez C, Kostine M, Truchetet ME. Lopez L, et al. Among authors: schaeverbeke t. Joint Bone Spine. 2023 May;90(3):105555. doi: 10.1016/j.jbspin.2023.105555. Epub 2023 Feb 25. Joint Bone Spine. 2023. PMID: 36842760
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM.
Ramiro S, Landewé R, van der Heijde D, Sepriano A, FitzGerald O, Østergaard M, Homik J, Elkayam O, Thorne JC, Larché MJ, Ferraccioli G, Backhaus M, Boire G, Combe B, Schaeverbeke T, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel AG, Allaart CF, Barnabe C, Bingham CO, van Schaardenburg D, Hammer HB, Dadashova R, Hutchings E, Paschke J, Maksymowych WP. Ramiro S, et al. Among authors: schaeverbeke t. Rheumatology (Oxford). 2023 Sep 1;62(9):2989-2997. doi: 10.1093/rheumatology/kead021. Rheumatology (Oxford). 2023. PMID: 36645243
186 results